$PATH

Malpani Raghavendra sold $414K of PATH

Malpani Raghavendra (CPO & CTO) sold 29,565 shares of UiPath, Inc. (PATH) at $14.00 ($0.41M total) on 2026-10-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Malpani Raghavendra
Published Oct 26, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PATH
Neutral
high confidence
Mentioned
$PATH
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHNeutralLow
01

Why it matters

The disclosed sale adds transparency but is unlikely to move the stock significantly.

02

Market read

A modest insider sell; limited trading relevance.

03

What to watch

Potential upcoming compensation grant or tax planning could be driving the sale.

Relevance 3/10Novelty 3/10Timing: today

Background

UiPath filed a Form 4 showing a 10b5-1 planned sale by its chief product and technology officer.

Company-level read

Ticker impact

$PATHNeutralHigh confidence
Context

CPO & CTO sold 29,565 shares for $413,963, a disclosed insider sale via Form 4.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

Form 4 filings are primary source; the amount is modest but may influence short‑term sentiment.

Market effects

Minimal impact on the broader RPA/software sector.

Limited to U.S. investors tracking UiPath.

Low global relevance.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Malpani Raghavendra

    Chief Product Officer & Chief Technology Officer of UiPath.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PATHMed

UiPath Stock Steadies As AI Agent Push Meets Wall Street Caution

UiPath Inc. (NYSE: PATH) shares rose 4.5% on September 30, 2026, driven by strong enterprise automation adoption and AI growth sentiment. The stock has been trading between $12.60 and $13.00, showing signs of stabilization. UiPath reported quarterly revenue of $410.3M, gross margin of 82.6%, and net income of $36.1M. The company is shifting focus to AI agents and orchestration, with aggressive long-term targets.